When exploring the landscape of metabolic research, one compound frequently surfaces in literature: AOD 9604. For those tracking the evolution of synthetic compounds, identifying the AOD 9604 peptide other name is essential for navigating scientific databases and understanding AOD‑9604 Peptide for Fat Loss: Mechanism, Benefits & its chemical lineage.
Decoding the Nomenclature: What is AOD 9604?
AOD 9604 is a synthetic analogue of the lipolytic domain of human growth hormone. Peptides for Weight Loss Explained: GLP-1, CJC-1295, The acronym itself stands for "Anti-Obesity Drug-9604." Because it is a specialized peptide fragment of human growth hormone (specifically the C-terminal region spanning amino acids 176-191), i Nov 2, 2025 — AOD 9604 stands for “Anti-Obesity Drug-9604”. It is a synthetic peptide fragment derived from the C-terminal (amino acids 176–191) of human t is often referred to by several technical aliases in laboratory settings. Peptides for Weight Loss Explained: GLP-1, CJC-1295,
AOD 9604 peptide, also called the fat-burning peptide, is an anti-obesity drug (AOD) that can also be used for losing weight for non-obese patients.Common identifiers include:
* Tyr-hGH fragment: This highlights its structural origin.
* Lipotropin: A term sometimes used to describe its functional classification.
* H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH: The full chemical sequence, which is the most accurate way to identify the molecule in structural databases.
Because AOD-9604 is a fragment of the human growth hormone molecule, it is distinct from full-chain hormones. Researchers often categorize it as a lipolytic fragment designed to isolate the metabolic signaling properties of the original hormone without the broader systemic effects associated with the full molecule.
Distinguishing AOD 9604 from Other Peptides
In the world of peptides, it is common for users to compare different compounds. While AOD 9604 is frequently discussed alongside other agents like Tirzepatide or Tesamorelin, it is important to note that these compounds work through different biological pathways.
For instance, while some agents influence insulin sensitivity or growth hormone secretagogue receptors, AOD 9604 is specifically engineered to interact with pathways associated with fat metabolism. Because of this specialized focus, it is often marketed as "HGH for fat loss," though this Mar 19, 2008 — AOD9604 is a synthetic analogue of the lipolytic domain of human growth hormone, being investigated for the treatment of obesity. shorthand can be misleading. It is more accurately described as a modified fragment that does not exert the same influence on IGF-1 levels as full-length growth hormone.
Technical Specifications and Research Context
For those examining the 9604 peptide, understanding its structural integrity is vital. The compound is a 16-amino acid sequence. Its CAS number, 221231-10-3, is the definitive identifier for researchers looking to verify the purity and source of the substance.
When discussing the AOD 9604 peptide, one must appreciate that it is a synthetic creation. The 9604 designation represents the specific developmental iteration that researchers found most stable for studying fat-burning processes in controlled environments. Whether you see it referred to as Aod-9604 or by its full sequence, you are looking at the same research-grade material.
Summary of Key Entities
* Core Entity: AOD 9604 (Anti-Obesity Drug-9604).
* Classification: Synthetic HGH fragment (176-191).
* Primary Function: Investigated for its role as a lipolytic fragment in metabolic research.
* Distinction: It is not a stimulant, nor does it function like a standard growth hormone secretagogue.
As research continues, the AOD 9604 peptide remains a significant subject for those interested in the underlying mechanisms of how specific amino acid sequences can influence fat metabolism. By focusing on the structural data—such as the sequence H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH—researchers can ensure they are working with the correct, high-quality material for their specific studies. Always ensure that any information regarding these compounds is sourced from reputable, peer-reviewed scientific Jan 6, 2026 — AOD-9604 is a modified fragment of human growth hormone (specifically amino acids 176-191) that has been engineered to target fat metabolism literature to maintain a high standard of accuracy and safety in your research endeavors.